Clinical trial
Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant
NCT00309309 · Mario Negri Institute for Pharmacological Research, Other · Completed
Key facts
| NCT number | NCT00309309 |
|---|---|
| Title | Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant |
| Official title | A Prospective, Longitudinal Study to Assess the Metabolic and Renal Effects of Rosiglitazone in Albuminuric Kidney Transplant Recipients |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Transplant |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 10 |
| Start date | Apr 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Mar 31, 2006 |
| Last update posted | Jul 3, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: